Sponsored by
For the Inventor. By the Inventor. With the Investor.
We curate this newsletter based on Patent Strengthāa metric of a patentās strategic value and its legal ability to withstand challenges.
Love our insights? Share them with your network and weāll send you our exclusive Patent Strength eBookāa masterclass in building and evaluating high-value portfolios.
How to get your copy:
Invite: Send your unique referral link to friends or colleagues who value tech innovation.
They Join: Once they subscribe, you're eligible.
Download: Weāll send the eBook straight to your inbox.
Help us grow the community and snag your Patent Strength eBook today!
Table of Contents
Breakthroughs - Companies covered:
The Thyroid Whisperer: Egetis Therapeutics (EGTX) secures tech to fix hormone signaling for the previously untreatable MCT8 deficiency.
The Gut Check: Johnson & Johnson (JNJ) debuts a "dual-wielding" co-antibody therapy to strike Crohnās disease from two sides at once.
Genetic Seed "Spin-Off" Tech: Corteva (CTVA) launches the "Vylor" brand, featuring proprietary genetics that turn barren land into viable cropland.
The GaN Ban: Infineon (IFNNY) secures a massive ITC win, effectively freezing competitors out of the high-efficiency semiconductor market.
RF Signal Fingerprinting: Newly IPOāed satellite tech validates a massive IP portfolio capable of tracking "dark ships" via their radio hum.
Cameras with Brains: VisionWave Holdings (VWAV) introduces xCalibreā¢, an AI architecture that turns standard video feeds into high-level tactical intelligence.
Recommendations
From IDiyas
Want your company featured to 50,000 plus innovation-minded readers? Sponsor an IDiyas article. Please see our newsletter stats. Send us an email to: [email protected] for details.
Newsletter published 3x weekly. Sign up by clicking on the image above.
š”ļøProtect Your Invention
Ready to file? Get a fast, free quote from our network of registered practitioners.
Interested in joining our network of registered practitioners?
Please contact us here.
Featured Sponsored Content
How Jennifer Anistonās LolaVie brand grew sales 40% with CTV ads
The DTC beauty category is crowded. To break through, Jennifer Anistonās brand LolaVie, worked with Roku Ads Manager to easily set up, test, and optimize CTV ad creatives. The campaign helped drive a big lift in sales and customer growth, helping LolaVie break through in the crowded beauty category.
š Biotech & Healthcare
The Thyroid Whisperer
š¬ The Tech: A novel pharmaceutical composition containing tiratricol. Itās designed to fix the broken thyroid hormone signaling in patients with MCT8 deficiency, a rare and nasty disease that previously had no real answer.
š Stock Ticker: EGTX (Egetis Therapeutics)
šļøāāļø Patent Strength: 92/100
šSource: Morningstar/Accesswire - May 5, 2026
š The Big Deal: This patent is "Orange Book-listable," which is pharma-speak for "we have a legal moat the size of the Atlantic." With FDA Priority Review, they are sprinting toward the finish line.
š The Domino Effect: If the FDA gives the green light in September, EGTX gets 7 years of orphan drug exclusivity, and patients finally get a treatment that actually works.
The Gut Check
š¬ The Tech: A co-antibody therapy (JNJ-4804) that pulls double duty by targeting both IL-23 and TNF-Ī±. Itās like hitting Crohnās disease with a two-handed broadsword instead of a butter knife.
š Stock Ticker: JNJ (Johnson & Johnson) šļøāāļø Patent Strength: 88/100
šSource: PR Newswire - May 5, 2026
š The Big Deal: Phase 2b data shows this beats the current gold standards. In the world of IBD, "better than the best" is a multi-billion dollar phrase.
š The Domino Effect: High remission rates lead to Phase 3 success, which leads to JNJ dominating the refractory IBD market, leaving competitors to wonder where their lunch went.
š Agriculture & Food Tech
Genetic Seed "Spin-Off" Tech
š¬ The Tech: Advanced seed and genetics IP associated with the brand-new "Vylor" brand. This covers proprietary traits that make crops grow in places usually reserved for cacti.
š Stock Ticker: NYSE: CTVA (Corteva)
šļøāāļø Patent Strength: 91/100
š Source: PR Newswire via Morningstar | May 4, 2026 š The Big Deal: By spinning this off into Vylor, Corteva is isolating its most valuable "genetic blueprints" for a pure-play market run.
š The Domino Effect: If Vylor dominates the 2027 planting season, then Cortevaās remaining business becomes a lean, mean, chemical machine.
Sponsored content
Imagine turning down Uber at $10Māonly to see it IPO at $80B.
Thatās what happened to Mark Cubanā¦ a 799,900% return, gone.
But Kevin Harrington built his reputation by spotting such opportunities early.
Like Uber turned vehicles into income-generating assets, Mode is turning phones into income streams, and you can still invest before they potentially go public.
Potential Uber return for Marc Cuban does not take into account dilution.
The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period in 2023.
Please read the offering circular at invest.modemobile.com. This is a paid advertisement for Mode Mobileās Regulation A Offering.
ā” Semiconductors & Hardware
The GaN Ban
Infineon just won a major ITC ruling, validating their Gallium Nitride (GaN) patents against Innoscience. This isn't just a win; it's a "stop shipping your stuff" order.
š¬ The Tech: Gallium Nitride (GaN) semiconductor manufacturing processes for high-efficiency power conversion.
š Stock Ticker: OTC: IFNNY
šļøāāļø Patent Strength: 98/100
š Source: PR Newswire via Manila Times, May 8, 2026
š The Big Deal: GaN makes chargers smaller and EVs travel further. Infineon just locked the door on a major competitor in the US.
š The Domino Effect: If Innoscience is banned ā Supply chains for cheap GaN components tighten ā Infineon raises prices ā Your next laptop brick costs $10 more.
š”ļø Defense & AI Intelligence
RF Signal Fingerprinting
š¬ The Tech: Satellite-based Radio Frequency (RF) signals intelligence mapping. While not a "new" patent this week, their IPO pricing (linked to their massive IP portfolio) validates the tech that can find a "dark ship" in the middle of the ocean just by its radio hum.
š Stock Ticker: NYSE: HAWK (HawkEye 360)
šļøāāļø Patent Strength: 96/100
š Source: PR Newswire | May 6, 2026
š The Big Deal: $416 million in IPO proceeds says the market believes their "patented orbital ears" are the future of global security.
š The Domino Effect: If the IPO capital is used to double their constellation size, then no one on Earth will be able to turn on a walkie-talkie without HawkEye knowing.
Cameras with Brains
š¬ The Tech: The xCalibreā¢ visual intelligence platform. Itās an architecture that converts standard camera streams into "structured sensor intelligence." Instead of just seeing a "blob," the camera identifies "Submarine, Type 094, 2 miles out, looks grumpy."
š Stock Ticker: NASDAQ: VWAV (VisionWave Holdings)
šļøāāļø Patent Strength: 89/100
š Source: PR Newswire via Finviz | May 4, 2026
š The Big Deal: Defense buyers are tired of paying for video; they want decisions. This patent places VisionWave at the center of the $3B military AI video market.
š The Domino Effect: If VisionWave integrates this into existing drone fleets, then "dumb" surveillance cameras globally become obsolete overnight.
Sponsored content
GTM Atlas, by Attio
GTM Atlas is a free resource every operator should read. Curated by Attio, the AI CRM, and written by GTM leaders from Lovable, Granola, and Vercel, you'll get:
ICP, outbound, and retention frameworks from operators who've built them
The qualification signals that actually predict conversion
Conversion plays that don't rely on a pitch deck
Mapped by operators. Curated by Attio.
Recommendations
The Tucker 48 was a radical leap forward, introducing safety features like a pop-out windshield and a directional "Cyclops" headlight decades before they became standard. Preston Tuckerās dream of disrupting the "Big Three" ended in a high-profile SEC trial and the collapse of his company, despite his eventual acquittal. While only 51 cars were built, the story is a powerful testament to visionary engineering. You should watch it to see the "David vs. Goliath" battle of a man whose ideas were too revolutionary for the era's establishment to allow.
From IDiyas
Donāt Bring a Knife to a Patent Fight
Navigating 9 million USPTO records is a great way to get a headacheāor a multi-million dollar lawsuit. UpFront Research Reports does the heavy lifting for you, distilling "patent-speak" into actionable intelligence with surgical precision. Whether youāre an investor hunting for the next tech unicorn or an attorney looking for the perfect expert witness, we provide the map to the minefield.
Stop guessing. Start knowing.
UpFront Research Report Library: Click on image to view our inventory and purchase reports
The Patent Ticker: Because by the time it's on a shelf, the money's already been made.
The Fine Print: The inventors are busy, the investors are greedy, and the patents are rolling in. A patent today doesnāt guarantee a profit tomorrow. IDiyas is a data and information platform, not a financial advisor. While we love tracking innovation, this newsletter is for educational purposes only. Always conduct your own due diligence before making any financial moves.